Conceptual Study on the add-on effect of Ushiradi Siddha Taila Pratimarsha Nasya in Senile Immature Cataract (Kaphaj Timir)
International Journal of Drug Delivery Technology · 08.06.2026 · 16 (47s)
DOI: 10.25258/ijddt.16.47s.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.06.2026. Verfasst von Prajkta Mal und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Cataract remains a pervasive degenerative ophthalmic condition, characterized by the progressive clouding and thickening of the crystalline lens. As the primary global cause of vision impairment and blindness, it poses a significant public health challenge, particularly among aging populations. Within the framework of Ayurvedic science, this progressive deterioration is correlated with Kaphaj Timir or Apakva Linganash. This pathology occurs when vitiated Kapha dosha obstructs the ocular patalas (layers), gradually diminishing visual clarity. While modern ophthalmology has made great strides in surgical intervention, there is a distinct lack of effective pharmacological treatments capable of preventing, delaying, or reversing lens degeneration once it begins. This conceptual study explores the therapeutic potential of Ushiradi Siddha Taila Pratimarsha Nasya, a traditional intervention detailed in the Sushruta Uttartantra. The treatment protocol involves the daily nasal administration of two drops of medicated oil in each nostril. This specific formulation is composed of potent Kapha shamaka herbs, including Ushira, Lodhra, Triphala, and Priyangu. These ingredients possess Ushna (hot) and Ruksha (dry) properties, which are theoretically essential for pacifying the dense, cold, and cloudy nature of the Kapha responsible for lens opacity. To validate this approach, a randomized controlled trial is proposed at the Bharati Vidyapeeth College of Ayurved and Hospital. The study will involve 45 participants aged 40-80 with immature cataracts and a visual acuity of 6/36 or better. These participants will be divided into three groups: Group A receiving the Nasya therapy, Group B using standard Catagon eye drops, and Group C receiving a combined therapy. The trial will span 120 days, assessing outcomes through subjective symptoms like blurred vision and glare, alongside objective measures such as LOGMAR visual acuity and slit-lamp photography. Ultimately, this research aims to establish an evidence-based Ayurvedic protocol that offers a non-invasive, cost-effective, and accessible avenue for managing senile immature cataracts, potentially reducing the global surgical burden.
Zitieren
APA
Mal, P., Mulik, S. S., Mulik, S. S., Satav, D., & Patil, A. (2026). Conceptual Study on the add-on effect of Ushiradi Siddha Taila Pratimarsha Nasya in Senile Immature Cataract (Kaphaj Timir). International Journal of Drug Delivery Technology, 16(47s). https://doi.org/10.25258/ijddt.16.47s.76
Vancouver
Mal P, Mulik SS, Mulik SS, Satav D, Patil A. Conceptual Study on the add-on effect of Ushiradi Siddha Taila Pratimarsha Nasya in Senile Immature Cataract (Kaphaj Timir). International Journal of Drug Delivery Technology. 2026;16(47s). doi:10.25258/ijddt.16.47s.76
BibTeX
@article{Mal2026,
author = {Mal, Prajkta and Mulik, Sarita S. and Mulik, Santosh S. and Satav, Durga and Patil, Amol},
title = {Conceptual Study on the add-on effect of Ushiradi Siddha Taila Pratimarsha Nasya in Senile Immature Cataract (Kaphaj Timir)},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {47s},
doi = {10.25258/ijddt.16.47s.76}
}
EUVIMED